Cervical Cancer Screening Cascade: A Framework for Monitoring Uptake and Retention Along the Screening and Treatment Pathway
Current Oncology · 2025
DOI: 10.3390/curroncol32070407 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, 2025. Verfasst von Sara Izadi-Najafabadi und 5 weiteren Autor:innen. Beteiligte Einrichtung: BC Cancer, Vancouver, BC V5Z 0B4, Canada. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research (CIHR).
Abstract (Originalsprache)
Background
Cervical cancer is a major global health concern, causing approximately 350,000 deaths annually. It is also preventable through effective prevention and early detection. To facilitate elimination, the World Health Organization (WHO) set targets for HPV vaccination, screening, and treatment. Achieving these goals requires frameworks to monitor screening program performance. As many regions transition to HPV primary screening, a standardized Cervical Cancer Screening Cascade can track performance, identify gaps in follow-up, and optimize resource allocation.
Methods
This paper introduces a structured cascade developed to monitor uptake, retention, and outcomes in HPV-based screening programs. The Cascade was created through collaboration between public health experts, clinicians, and researchers at the University of British Columbia (UBC), the Women’s Health Research Institute, and BC Cancer.
Results
The Cascade outlines four phases: screening, triage, detection, and treatment. Each phase includes two substages: “uptake” and “results,” with an additional substage in screening (“invitation”). “Screening” assesses invitation effectiveness and participation. “Triage” tracks follow-up after a positive screen. “Detection” evaluates attendance at diagnostic appointments, and “Treatment” measures the treatment rate for those with precancerous lesions.
Conclusions
The Cascade can guide emerging and existing HPV screening programs within Canada and other similarly resourced settings and serve as a benchmark tool for programs to assess their progress towards cervical cancer elimination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- BC Cancer, Vancouver, BC V5Z 0B4, Canada.
- Women's Health Research Institute, BC Women's Hospital, Vancouver, BC V6H 3N1, Canada.
- Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.
- School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
- Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
ORCID-Profile: Anna Gottschlich, Stuart Peacock
Förderung
- CIHR
- Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Izadi-Najafabadi, S., Smith, L. W., Gottschlich, A., Booth, A., Peacock, S., & Ogilvie, G. S. (2025). Cervical Cancer Screening Cascade: A Framework for Monitoring Uptake and Retention Along the Screening and Treatment Pathway. Current Oncology. https://doi.org/10.3390/curroncol32070407
Vancouver
Izadi-Najafabadi S, Smith LW, Gottschlich A, Booth A, Peacock S, Ogilvie GS. Cervical Cancer Screening Cascade: A Framework for Monitoring Uptake and Retention Along the Screening and Treatment Pathway. Current Oncology. 2025. doi:10.3390/curroncol32070407
BibTeX
@article{IzadiNajafabadi2025,
author = {Izadi-Najafabadi, Sara and Smith, Laurie W and Gottschlich, Anna and Booth, Amy and Peacock, Stuart and Ogilvie, Gina S},
title = {Cervical Cancer Screening Cascade: A Framework for Monitoring Uptake and Retention Along the Screening and Treatment Pathway},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32070407}
}
EUVIMED